Pursuing Deeper Responses With Linvoseltamab - HealthTree for Multiple Myeloma
[logo] HealthTree Foundation
more_vert
close
person Sign In / Create Account

Pursuing Deeper Responses With Linvoseltamab in Newly Diagnosed Multiple Myeloma Patients

Pursuing Deeper Responses With Linvoseltamab in Newly Diagnosed Multiple Myeloma Patients image

Pursuing Deeper Responses With Linvoseltamab in Newly Diagnosed Multiple Myeloma Patients

Webinar
event Oct 07, 2024 / 02:00PM - 03:00PM EDT
link icon facebook logo X logo linkedin logo reddit logo email icon

Event Description

This webinar will focus on how linvoseltamab, might be used to achieve deeper treatment responses for newly diagnosed myeloma patients who do not reach MRD (minimal residual disease) negativity after initial therapy. We will discuss how this strategy may delay the need for a transplant while offering patients more effective long-term control of their disease. Dr. Kazandjian and Kellye, APRN from the University of Miami Sylvester Comprehensive Cancer Center will join us to discuss this exciting new research.

Event Highlights

Reevaluation of the Role of Autologous Stem Cell Transplant (ASCT)

expand_more

Advances in Treatment and Diagnostic Technologies

expand_more

ImmunoPLANT Trial Targeting MRD Positive Patients

expand_more

Potential of Linvoseltamab as a Novel Treatment Option

expand_more

Questions & Answers

expand_more

Schedule & Agenda

The panelist Cynthia Cahoon, RN
2:00 PM
Introductions
Cynthia Cahoon, RN

Cynthia introduces the agenda of the event and featured speakers Dickran Kazandjian, MD & Kellye Koubek, MS, APRN, AGNP-C

Event panelist Dr. Kazandjian and Kellye Koubek
2:05 PM
Presentation
Dr. Kazandjian and Kellye Koubek

Dr. Kazandjian and Kellye Koubek share about Linvoseltamab for newly diagnosed patients

Event panelist Audience
2:35 PM
Questions and Answers
Audience

Type your questions in the chat and we will answer them! 

Speakers & Moderators

The panelist Cynthia Cahoon, RN
Cynthia Cahoon, RN

Cynthia is a newborn ICU nurse by trade that has spent the last six years in the medical device industry educating nurses and doctors about devices that are new to their facility. In her spare time she enjoys hiking, traveling the world with her family, and creating Halloween animatronics for her annual front yard display. She has a passion for life-long learning and enjoys sharing what she learns with the people around her.

Read Bio
The panelist Dickran Kazandjian, MD
Dickran Kazandjian, MD

Dr. Kazandjian’s clinical and translational research interests lie in the treatment of precursor plasma cell disorders including high risk smoldering multiple myeloma and the role of immunotherapy in plasma cell dyscrasias. In addition, he is re-evaluating the role of autologous stem cell transplant (ASCT) in the era of highly efficacious novel-novel drugs, immunotherapy biologics, and cell-based therapies with the hypothesis that certain subsets of patients with myeloma may not benefit by default upfront ASCT.

Read Bio
The panelist Kellye Koubek, MS, APRN, AGNP-C
Kellye Koubek, MS, APRN, AGNP-C

Kellye Koubek is an Advanced Practice Registered Nurse at the University of Miami’s Sylvester Comprehensive Cancer Center.  After graduating in 2011 with a Bachelor of Science in Nursing from Xavier University, Kellye Koubek gained valuable experience working as a registered nurse in various hospital platforms. She then pursued a Master of Science from Hunter College in New York City, graduating in 2021 from Hunter’s Adult-Gerontology Primary Care Nurse Practitioner program. Her commitment to advancing oncology research is underscored by her prior experience as a Clinical Trial Nurse at Memorial Sloan Kettering Cancer Center. Currently, Kellye serves as a Research Advanced Practice Nurse at the Sylvester Myeloma Institute, specializing in plasma cell disorders. Beyond her clinical duties, Kellye actively contributes to the advancement of medical science by serving as a sub-investigator for interventional clinical trials, playing a crucial role in the implementation and development of research trials, and facilitating the dissemination of clinical trial findings.

Read Bio
HealthTree Connect Icon

Join the Conversation

This event is part of the Newly Diagnosed group in HealthTree Connect, a social media platform for people with blood cancer. If you want to connect with other patients and caregivers and talk about this topic, join HealthTree Connect.

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

Thanks to our sponsors:
Johnson and Johnson logo
Sanofi logo
Adaptive logo
Pfizer logo
GSK logo
Regeneron logo
All HealthTree resources available anywhere, anytime
Download our App
Download iOS App Download Android App
iphone app mockup
newsletter icon

Get the Latest Multiple Myeloma Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.